Keyphrases
Prostate Cancer Risk
100%
Cancer Clinical Trials
100%
European Randomized Study of Screening for Prostate Cancer
100%
PLCO Trial
100%
United States
22%
Prostate Cancer Screening
22%
Intervention Group
22%
Diagnostic Work-up
22%
Europe
11%
Increased Incidence
11%
Prostate Cancer Survival
11%
Low Risk
11%
Randomized Controlled Trial
11%
Ovarian Cancer Screening
11%
Colorectal Cancer Screening
11%
Lung Cancer Screening
11%
National Cancer Institute
11%
Cox Regression
11%
Funding Sources
11%
Cancer Control
11%
Estimation Approaches
11%
Analytic Model
11%
Microsimulation Model
11%
Lead Time Estimation
11%
Medicine and Dentistry
Cancer Mortality
100%
Prostate Cancer
100%
Cancer Incidence
11%
Malignant Neoplasm
5%
Randomized Controlled Trial
5%
Proportional Hazards Model
5%
Cancer Survival
5%
Lung Cancer Screening
5%
Ovarian Cancer Screening
5%
Colorectal Cancer Screening
5%
Cancer Control
5%
Group Trial
5%
Time Perception
5%
Cancer Screening
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cancer Mortality
100%
Cancer Incidence
11%
Malignant Neoplasm
5%
Cancer Survival
5%
Randomized Controlled Trial
5%
Ovary Cancer
5%
Group Trial
5%